Literature DB >> 31752513

A User's Guide to the Inverted Terminal Repeats of Adeno-Associated Virus.

Patrick Wilmott1, Leszek Lisowski1,2,3, Ian E Alexander4,5, Grant J Logan5.   

Abstract

Ongoing development of recombinant vectors based on adeno-associated virus (rAAV) is providing an increasingly powerful and widely used toolkit for gene transfer and genome editing applications. While conceptually simple, the system harbors considerable complexity that presents many potential pitfalls for the inexperienced user. The short inverted terminal repeats (ITRs) can prove to be particularly problematic during vector engineering due to inherent instability necessitating diligent quality control measures during vector manufacture. This is especially important from a clinical standpoint when consistent purity and potency are paramount, and all components of the system are rigorously scrutinized by regulatory agencies. Despite the discovery over 30 years ago that the AAV ITRs are the only cis-acting elements of the virus required for vector production, there is a scarcity of reviews specifically focused on these complex elements. This review provides an overview of the ITR with the dual purpose of acting as a user's guide in the application of AAV vector technology and as a roadmap for ongoing vector development and optimization.

Entities:  

Keywords:  AAV; ITR; adeno-associated virus; inverted terminal repeats; quality control

Mesh:

Year:  2019        PMID: 31752513     DOI: 10.1089/hgtb.2019.276

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  7 in total

1.  Adeno-Associated Virus Vector Mobilization, Risk Versus Reality.

Authors:  Liujiang Song; R Jude Samulski; Matthew L Hirsch
Journal:  Hum Gene Ther       Date:  2020-10       Impact factor: 5.695

2.  Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression.

Authors:  Lauriel F Earley; Laura M Conatser; Victoria M Lue; Amanda L Dobbins; Chengwen Li; Matthew L Hirsch; R Jude Samulski
Journal:  Hum Gene Ther       Date:  2020-02       Impact factor: 5.695

3.  Human and Insect Cell-Produced Recombinant Adeno-Associated Viruses Show Differences in Genome Heterogeneity.

Authors:  Ngoc Tam Tran; Emilie Lecomte; Sylvie Saleun; Suk Namkung; Cécile Robin; Kristina Weber; Eric Devine; Veronique Blouin; Oumeya Adjali; Eduard Ayuso; Guangping Gao; Magalie Penaud-Budloo; Phillip W L Tai
Journal:  Hum Gene Ther       Date:  2022-04       Impact factor: 4.793

4.  Rational engineering of a functional CpG-free ITR for AAV gene therapy.

Authors:  Xiufang Pan; Yongping Yue; Maria Boftsi; Lakmini P Wasala; Ngoc Tam Tran; Keqing Zhang; David J Pintel; Phillip W L Tai; Dongsheng Duan
Journal:  Gene Ther       Date:  2021-10-06       Impact factor: 4.184

5.  Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells.

Authors:  Samuele Ferrari; Aurelien Jacob; Daniela Cesana; Marianne Laugel; Stefano Beretta; Angelica Varesi; Giulia Unali; Anastasia Conti; Daniele Canarutto; Luisa Albano; Andrea Calabria; Valentina Vavassori; Carlo Cipriani; Maria Carmina Castiello; Simona Esposito; Chiara Brombin; Federica Cugnata; Oumeya Adjali; Eduard Ayuso; Ivan Merelli; Anna Villa; Raffaella Di Micco; Anna Kajaste-Rudnitski; Eugenio Montini; Magalie Penaud-Budloo; Luigi Naldini
Journal:  Cell Stem Cell       Date:  2022-10-06       Impact factor: 25.269

Review 6.  Next Step in Gene Delivery: Modern Approaches and Further Perspectives of AAV Tropism Modification.

Authors:  Maxim A Korneyenkov; Andrey A Zamyatnin
Journal:  Pharmaceutics       Date:  2021-05-19       Impact factor: 6.321

Review 7.  PCR-Based Analytical Methods for Quantification and Quality Control of Recombinant Adeno-Associated Viral Vector Preparations.

Authors:  Anna A Shmidt; Tatiana V Egorova
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.